Skip to main content

Table 1 Baseline patient characteristics

From: Where is the exact origin of narrow premature ventricular contractions manifesting qR in inferior wall leads?

Patient

Age (y)

Sex

PVC count (number/24 h)

Symptoms

Symptom duration (M)

AADs used

Comorbidities

LVEF (%)

LVEDd (mm)

1

38

M

11026

palpitation

23

Beta-blocker,

Propafenone

none

65

58

2

47

F

20348

palpitation

14

Beta-blocker

none

59

49

3

27

F

18265

palpitation

18

Beta-blocker

none

68

45

4

35

F

13529

palpitation

9

Beta-blocker,

Mexiletine

none

67

44

5

24

M

22057

palpitation

22

Beta-blocker,

Propafenone

none

66

47

6

41

M

32784

palpitation

38

Beta-blocker,

Propafenone

none

69

48

7

21

F

12683

palpitation

16

Beta-blocker,

Propafenone

none

66

46

8

27

F

21522

palpitation

32

Beta-blocker

none

63

49

9

15

M

32657

palpitation,

chest pain

26

Beta-blocker,

Amiodarone

none

62

43

10

62

M

32158

Palpitation

chest pain

39

Beta-blocker,

Mexiletine,

hypertension

66

41

11

34

F

26712

Palpitation

48

Beta-blocker

none

67

47

12

28

M

15336

Palpitation

18

Beta-blocker,

Mexiletine

none

65

48

13

14

F

28637

Palpitation,

chest pain

46

Beta-blocker,

Propafenone

none

66

42

14

42

F

24512

Palpitation

13

Beta-blocker

none

59

47

15

13

M

24104

palpitation

16

Beta-blocker,

Propafenone

none

65

51

16

22

F

16248

palpitation

10

Beta-blocker

none

58

46

17

65

F

16412

palpitation

16

Beta-blocker,

Amiodarone

diabetes

62

47

18

37

M

20119

palpitation

6

Beta-blocker

none

62

46

19

29

M

SVT

palpitation

18

Beta-blocker

none

65

46

20

39

F

13008

palpitation,

chest pain

6

Beta-blocker,

Propafenone

none

62

48

21

25

M

20116

palpitation

26

Beta-blocker

none

65

49

22

36

M

16551

Palpitation

13

Beta-blocker,

Propafenone

none

66

47

23

44

F

9807

palpitation,

chest pain

28

Beta-blocker,

Propafenone

none

68

47

24

58

M

16579

Palpitation

22

Beta-blocker,

Propafenone

hypertension

66

49

25

33

F

22172

Palpitation

24

Beta-blocker,

Propafenone

none

65

48

26

54

F

18613

Palpitation

20

-

hypertension

42

61

27

32

M

24007

palpitation

16

Beta-blocker,

Amiodarone

none

65

46

28

27

F

21038

palpitation

5

Beta-blocker,

Propafenone

none

63

47

29

29

M

15416

palpitation

22

Beta-blocker

none

67

48

30

32

F

19478

palpitation

24

Beta-blocker,

Propafenone, Mexiletine

none

64

47

31

34

F

22342

palpitation

2

Beta-blocker,

Propafenone,

none

68

46

32

33

F

12763

palpitation

6

Beta-blocker,

Propafenone,

none

68

47

33

24

F

12913

palpitation

5

Beta-blocker,

Propafenone,

none

70

46

34

22

F

15692

palpitation

24

Beta-blocker,

Propafenone,

none

68

45

35

62

M

26314

palpitation

12

Beta-blocker

none

66

50

36

50

F

15213

palpitation

16

Beta-blocker,

Propafenone,

none

65

48

37

24

F

16327

palpitation

38

Beta-blocker,

Propafenone,

none

66

46

38

40

F

18706

palpitation

26

Beta-blocker,

Propafenone,

none

66

48

39

50

M

20522

palpitation

32

Beta-blocker,

Propafenone,

none

65

48

40

38

M

12637

palpitation

16

Beta-blocker,

Propafenone,

none

68

46

Mean ± SD

33.53 ± 12.48

 

20231 ± 6102

 

20.08 ± 11.28

  

64.88 ± 2.76

46.69 ± 2.28

  1. Annotation:Y years, M Months, AADs antiarrhythmic drugs, LVEF left ventricular ejection fraction, LVEDd left ventricular end-diastolic internal diameter